ISM004-1057D

N/A

Report date: 2022/02/20 11:09:44
NME

Base Information

Drug NameISM004-1057D
Drug Alias NameISM004-1057D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminyl-peptide cyclotransferase-like protein inhibitors
TargetsGlutaminyl-peptide cyclotransferase-like protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInsilico Medicine LtdShanghai Fosun Pharmaceutical (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A